logo

Search projects

Examples: APPROACH

10 projects found

AB-Direct
f4571618-5f11-11eb-917b-acde48001122

Antibiotic distribution and recovery in tissue

Keywords: IMI projects Antimicrobial resistance Infectious diseases AMR Accelerator Conducting clinical trials

AMR Accelerator
effc9746-5f11-11eb-917b-acde48001122

Antimicrobial Resistance Accelerator. Umbrella programme comprising the IMI projects AB-DIRECT, COMBINE, ERA4TB, GNA NOW, PRIMAVERA, RespiriNTM, RespiriTB, TRIC-TB and UNITE4TB

Keywords: IMI projects Antimicrobial resistance Infectious diseases AMR Accelerator Clinical trial design Conducting clinical trials

COMBINE
f435321e-5f11-11eb-917b-acde48001122

Collaboration for prevention and treatment of MDR bacterial infections

Keywords: IMI projects Antimicrobial resistance Infectious diseases AMR Accelerator Tools for predicting/monitoring efficacy Tools for predicting/monitoring safety Clinical trial design

fairplus stamp

ERA4TB
f17922f6-5f11-11eb-917b-acde48001122

European regimen accelerator for tuberculosis

Keywords: IMI projects Antimicrobial resistance Infectious diseases AMR Accelerator

GNA NOW
f48896de-5f11-11eb-917b-acde48001122

Novel Gram-negative antibiotic now

Keywords: IMI projects Antimicrobial resistance Infectious diseases AMR Accelerator Conducting clinical trials

fairplus stamp

PRIMAVERA
c905e85a-c98a-11ed-a11d-ea435b63c148

Predicting the impact of monoclonal antibodies & vaccines on antimicrobial resistance

Keywords: IMI projects Antimicrobial resistance Infectious diseases Vaccines Biologicals AMR Accelerator Economic model

RespiriNTM
f4e40262-5f11-11eb-917b-acde48001122

Progress novel assets (one FIH start) for non-tubercular mycobacteria that may act synergistically with bedaquiline and cytochrome bc drugs

Keywords: IMI projects Antimicrobial resistance Infectious diseases AMR Accelerator Conducting clinical trials Target identification

RespiriTB
f32fb9f2-5f11-11eb-917b-acde48001122

Progress new assets (one pre-new molecular entity and one first-time-in-human start) for tuberculosis that act synergistically with bedaquiline, cytochrome bc or cytochrome bd inhibitors

Keywords: IMI projects Antimicrobial resistance Infectious diseases AMR Accelerator Conducting clinical trials